Top Markets
Coin of the day
Pharnext S.A. Pharnext S.A.

Pharnext S.A.

ALPHA
주식 순위 #42432
Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm... Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm dedicated to creating treatments for a range of neurodegenerative disorders, encompassing both rare (orphan) and common forms. Its pipeline features SYNGILITY, which has advanced through Phase III trials for Charcot-Marie-Tooth disease type 1A (CMT1A). Additionally, PXT864 has concluded Phase II clinical studies for Alzheimer's disease, and is also being explored for its potential in Parkinson's disease and amyotrophic lateral sclerosis (ALS). Pharnext also innovates with PLEOTHERAPY, a proprietary platform that harnesses big genetic data and artificial intelligence. In a collaborative effort, the company holds an agreement with the University Hospital Institute Mediterranee Infection to assess existing pharmaceuticals for their potential application against the COVID-19 virus. The organization was established in 2007, with its main offices located in Issy-Les-Moulineaux, France.
주가
$0.00023723
마지막 동기화: 2024-08-26
시가총액
$1.41K
변동 (1일)
111.67%
변동 (1년)
0.00%
국가
FR
거래 Pharnext S.A. (ALPHA)

카테고리

Pharnext S.A. (ALPHA)의 발행 주식 수
December 2023 기준 발행 주식 수: 736.02K
Pharnext S.A.의 최신 재무 보고서와 주가에 따르면 현재 발행 주식 수는 736.02K입니다. December 2022 말 기준 회사는 736.02K주를 발행했습니다. 발행 주식 수는 일반적으로 주식 분할이나 자사주 매입에 의해 영향을 받습니다.
Pharnext S.A. (ALPHA)의 발행 주식 수 기록 (2013 ~ 2026)
매년 말 기준 발행 주식 수
연도 발행 주식 수 변화
2026 (TTM) 736.02K 0.00%
2023 736.02K 0.00%
2022 736.02K 0.00%
2021 736.02K 0.00%
2020 736.02K 0.00%
2019 736.02K 0.00%
2018 736.02K 0.00%
2017 736.02K 0.00%
2016 736.02K 0.00%
2015 736.02K 0.00%
2014 736.02K 0.00%
2013 736.02K 0.00%
유사 기업 또는 경쟁사의 발행 주식 수
회사 발행 주식 수 차이 국가
253.90M 34,396.16%
US
62.19M 8,348.83%
NL
- -
CH
0.00 -100.00%
BE
- -
KR